Hereditary Cancer Diagnostic Panel

Assessing the hereditary risk for major cancer variants, including rare disease types.

Centogene Diagnostics tests will guide providers to indicate genetic mutation of hereditary nature by providing information from

BRCA 1 and BRCA 2 Whole gene sequencing
Clinical exome sequencing Cancer bearing gene of significance

Why Sayre-Centogene Collaboration

  • Global genotype-phenotype database for rare diseases CentoMD® and CentoPharma®
  • Advanced logistical solutions from sample sending (based on our CE-labeled CentoCard®) to report administration (using CentoPortal®)
  • High quality medical consultation
  • Quick turnaround time and fast reporting

For more information on centogene :

Please refer https://www.centogene.com/genetic-testing/disease-categories/oncogenetics.html or

Contact your local sales representative or Email us at info@sayretherapeutics.com